The Column Group (TCG), a biotech venture capital firm focused on building innovative drug discovery companies, announced the closing of The Column Group IV (TCG
The Column Group announced the recruitment of Dr. Helen Hobbs to the firm’s renowned group of Science Partners. Dr. Hobbs is Professor of Internal Medicine